Shares of Biocon soared over 3 per cent on the Bombay Stock Exchange after the company said that its insulin facility in Malaysia received compliance certificate.
Biocon said its subsidiary in Malaysia, Biocon Sdn. Bhd., received a certificate of 'GMP (Good Manufacturing Practice) Compliance' for its Insulins manufacturing facility by the HPRA (Ireland) as the representative European inspection authority.
Following the statement, shares of the company gained as much as 3.18 per cent to trade at Rs 345.80 apiece on the Bombay Stock Exchange.
In a similar fashion, shares of the company were trading 3.24 per cent higher at Rs 345.60 apiece on the National Stock Exchange.
Meanwhile, the broader benchmark BSE Sensex was trading at 31,711.70, up 48.96 points, or 0.15 per cent, at 11:55 hours.